Logo image of RESN

RESONANT INC (RESN) Stock Fundamental Analysis

NASDAQ:RESN - Nasdaq - Common Stock

4.48  -0.01 (-0.22%)

After market: 4.48 0 (0%)

Fundamental Rating

2

Taking everything into account, RESN scores 2 out of 10 in our fundamental rating. RESN was compared to 49 industry peers in the Communications Equipment industry. RESN may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, RESN is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

RESN had negative earnings in the past year.
RESN Yearly Net Income VS EBIT VS OCF VS FCFRESN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 -10M -20M -30M

1.2 Ratios

Industry RankSector Rank
ROA -126.82%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RESN Yearly ROA, ROE, ROICRESN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 -100 -200 -300

1.3 Margins

The Operating Margin and Gross Margin are not available for RESN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) -1649.86%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RESN Yearly Profit, Operating, Gross MarginsRESN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 -1K -2K -3K -4K -5K

More info and screens

3

2. Health

2.1 Basic Checks

RESN has more shares outstanding than it did 1 year ago.
The debt/assets ratio for RESN has been reduced compared to a year ago.
RESN Yearly Shares OutstandingRESN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M
RESN Yearly Total Debt VS Total AssetsRESN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 10M 20M 30M

2.2 Solvency

Based on the Altman-Z score of 1.08, we must say that RESN is in the distress zone and has some risk of bankruptcy.
A Debt/Equity ratio of 0.01 indicates that RESN is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 1.08
ROIC/WACCN/A
WACCN/A
RESN Yearly LT Debt VS Equity VS FCFRESN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 10M -10M 20M -20M

2.3 Liquidity

A Current Ratio of 3.13 indicates that RESN has no problem at all paying its short term obligations.
RESN has a Quick Ratio of 3.13. This indicates that RESN is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 3.13
Quick Ratio 3.13
RESN Yearly Current Assets VS Current LiabilitesRESN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 5M 10M 15M 20M 25M

More info and screens

5

3. Growth

3.1 Past

RESN shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -1.45%.
Looking at the last year, RESN shows a very negative growth in Revenue. The Revenue has decreased by -31.01% in the last year.
Measured over the past years, RESN shows a very strong growth in Revenue. The Revenue has been growing by 48.66% on average per year.
EPS 1Y (TTM)-1.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1.68%
Revenue 1Y (TTM)-31.01%
Revenue growth 3Y61.2%
Revenue growth 5Y48.66%
Sales Q2Q%-12.95%

3.2 Future

The Earnings Per Share is expected to grow by 1.36% on average over the next years.
Based on estimates for the next years, RESN will show a very strong growth in Revenue. The Revenue will grow by 110.03% on average per year.
EPS Next Y24.88%
EPS Next 2Y7.44%
EPS Next 3Y0.95%
EPS Next 5Y1.36%
Revenue Next Year265.95%
Revenue Next 2Y189.1%
Revenue Next 3Y169.02%
Revenue Next 5Y110.03%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
RESN Yearly Revenue VS EstimatesRESN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
RESN Yearly EPS VS EstimatesRESN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RESN. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for RESN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RESN Price Earnings VS Forward Price EarningsRESN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -8.14
RESN Per share dataRESN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y7.44%
EPS Next 3Y0.95%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for RESN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

RESONANT INC

NASDAQ:RESN (3/25/2022, 8:14:03 PM)

After market: 4.48 0 (0%)

4.48

-0.01 (-0.22%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryCommunications Equipment
Earnings (Last)03-22 2022-03-22/bmo
Earnings (Next)04-26 2022-04-26
Inst Owners0%
Inst Owner Change0%
Ins Owners2.86%
Ins Owner Change0%
Market Cap301.01M
Analysts74.55
Price Target4.59 (2.46%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 138.08
P/FCF N/A
P/OCF N/A
P/B 19.73
P/tB N/A
EV/EBITDA -8.14
EPS(TTM)-0.57
EYN/A
EPS(NY)-0.31
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.03
BVpS0.23
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -126.82%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) -1649.86%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.13
Quick Ratio 3.13
Altman-Z 1.08
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1.68%
EPS Next Y24.88%
EPS Next 2Y7.44%
EPS Next 3Y0.95%
EPS Next 5Y1.36%
Revenue 1Y (TTM)-31.01%
Revenue growth 3Y61.2%
Revenue growth 5Y48.66%
Sales Q2Q%-12.95%
Revenue Next Year265.95%
Revenue Next 2Y189.1%
Revenue Next 3Y169.02%
Revenue Next 5Y110.03%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A